University of British Columbia Medical School, Vancouver, BC, Canada.
Can J Ophthalmol. 2010 Feb;45(1):52-7. doi: 10.3129/i09-204.
To evaluate whether the addition of intracameral lidocaine to topical anaesthesia during cataract surgery leads to a decrease in the administration of intraoperative midazolam and fentanyl.
Retrospective case-control study.
The eyes of 124 patients undergoing phacoemulsification were included in the study, with 62 in the intracameral group and 62 in the control group.
A single-centre, retrospective chart review of cases between April and October 2007 in which patients had undergone small-incision phacoemulsification with foldable intraocular lens insertion and received preoperatively either topical tetracaine 0.5% with unpreserved intracameral lidocaine 1% (intracameral group) or topical tetracaine 0.5% alone (control group). Intraoperatively, midazolam and fentanyl were administered as needed based on pain and anxiety.
A total of 124 eyes (124 patients) were included. There was no statistically significant difference between the mean intraoperative midazolam doses given for the 2 groups (p = 0.08). The mean intraoperative dose of fentanyl was lower in the intracameral than in the control group (p < 0.0001). A comparison of intraoperative fentanyl requirements between groups using a multivariate regression analysis for age, gender, surgical time, and preoperative fentanyl levels confirmed the lower need for intraoperative fentanyl in the intracameral compared with the control group (p = 0.0037). There were no anaesthetic complications among any of the study patients.
Patients receiving topical tetracaine 0.5% with unpreserved intracameral lidocaine 1% during cataract surgery demonstrated a reduction in intraoperative fentanyl requirements. Surgeons performing cataract surgery under topical anaesthesia should consider the addition of intracameral lidocaine 1% to decrease fentanyl requirements and improve patient safety and comfort.
评估白内障手术中局部麻醉时在眼内注射利多卡因是否会减少术中咪达唑仑和芬太尼的使用。
回顾性病例对照研究。
本研究纳入了 124 例接受超声乳化白内障吸除术的患者,其中 62 例患者在眼内注射利多卡因组,62 例患者在对照组。
这是 2007 年 4 月至 10 月间在单一中心进行的回顾性图表审查,对接受小切口超声乳化白内障吸除术并植入折叠式人工晶状体的患者进行分析,这些患者术前接受局部滴用 0.5%盐酸丁卡因和未保存的 1%眼内利多卡因(眼内注射利多卡因组)或单独局部滴用 0.5%盐酸丁卡因(对照组)。术中根据疼痛和焦虑情况按需给予咪达唑仑和芬太尼。
共纳入 124 只眼(124 例患者)。两组患者术中咪达唑仑的平均剂量无统计学差异(p = 0.08)。眼内注射利多卡因组患者术中芬太尼的平均剂量低于对照组(p < 0.0001)。采用多元回归分析比较两组患者的术中芬太尼需求,分析年龄、性别、手术时间和术前芬太尼水平等因素,结果证实眼内注射利多卡因组术中芬太尼需求低于对照组(p = 0.0037)。研究患者中均无麻醉并发症。
在白内障手术中局部滴用 0.5%盐酸丁卡因和未保存的 1%眼内利多卡因可减少术中芬太尼的需求。行局部麻醉下白内障手术的外科医生应考虑在眼内注射 1%利多卡因,以减少芬太尼的需求,提高患者的安全性和舒适度。